drugset / Trial / NCT06531837

Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury

NCT06531837

Not yet recruiting 60 enrolled Beijing Tiantan Hospital
Non-randomizedParallel-groupOpen-labelOther

Summary

The diagnosis of chronic pain currently lacks objective and quantifiable biomarkers. This study aims to observe the EEG characteristics of patients with chronic pain following spinal cord injury and subsequently administer analgesic interventions with remifentanil, esketamine, flurbiprofen, and spinal cord stimulation. The correlation between EEG features and pain intensity will be examined. The research aims to advance the objectification of chronic pain diagnosis and treatment.

Timeline

Start
2024-08-25
Primary completion
2026-01-31
Completion
2026-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.2 mg/kg Intravenous
Subject Flurbiprofen Small molecule 100 mg Intravenous
Subject Remifentanil Small molecule

Indications